Presentation TCTAP 2013

Controversies: TAVI is Preferred in All High-Risk Patients

Presenter: Alain Cribier

April 24, 2013

REGISTER for free or LOG IN to view this content

Controversies: TAVI is Preferred in All High-Risk Patients

Aortic Valve

Presentation

TCTAP 2013

Up Next

Presentation TCTAP 2013

ESSENCE-DIABETES II Trial

Presenter: Gyung-Min Park

April 25, 2013

More slides +

Presentation TCTAP 2013

Lessons from European Registries

Presenter: Alain Cribier

April 25, 2013

Presentation TCTAP 2013

In-hospital outcome of interventional treatment in elderly patients with acute coronary syndromes

Presenter: W. Wojakowski

April 25, 2013

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.